India Launches Historic Rs 1 Lakh Crore Fund to Accelerate Private Sector Research and Innovation in Healthcare and Beyond

In a landmark move to transform the country’s research and innovation landscape, the Anusandhan National Research Foundation (ANRF) has approved a colossal Rs 1 lakh crore (approximately US$11.68 billion) fund aimed at catalyzing private-sector-led research, development, and innovation (RDI) across high-growth strategic sectors including healthcare, artificial intelligence, green technologies, and deep-tech. Announced in late 2025, this initiative reflects India’s commitment to becoming a global science and technology powerhouse by bridging long-standing gaps in private R&D investment and fostering an innovation-driven economy.

This transformative Rs 1 lakh crore fund, managed through a specially established Special Purpose Fund (SPF) within ANRF, does not directly invest in startups or industries. Instead, it channels capital via second-level fund managers such as Alternative Investment Funds, Development Finance Institutions, and Non-banking Financial Companies, who evaluate and deploy capital primarily as low-interest loans or equity infusions to promising R&D projects. This novel two-tier funding structure aims to ensure professional, transparent governance involving experts from the financial, business, and technical domains operating independently from direct government control.

Key Developments and Governance Framework

The establishment of this fund followed the Union Cabinet’s approval in mid-2025 and aligns with the ANRF Act of 2023 — a legislative effort to democratize research funding and foster collaboration between academia, government research institutions, private industry, and state governments. The scheme operates under the Department of Science and Technology, which witnessed a tenfold budget increase over the past decade, signaling the government’s prioritization of innovation.

The ANRF’s governance framework incorporates stringent special financial rules and implementation guidelines formulated with inputs from the Department of Economic Affairs and Department of Expenditure. An empowered group of secretaries oversees execution to ensure strategic alignment with national priorities, seamless fund disbursement, and accountability.

Expert Perspectives on Impact and Innovation

Dr. Shivkumar Kalyanaraman, CEO of ANRF, emphasizes that the fund addresses critical obstacles in India’s R&D ecosystem by providing accessible long-term capital where traditional private investment has shown reluctance: “This initiative is designed for high-gestation projects that require patient capital, fostering mission-oriented research and enabling India to leap from technology consumer to innovator on the global stage.”

Healthcare innovation, in particular, stands to benefit significantly. For instance, Dr. Rohit Kumar H.G., a leading grants manager and science columnist specializing in MedTech innovation, notes that ANRF’s programs like the MAHA MedTech Mission will leverage such funds to accelerate the development and commercialization of affordable, indigenous medical technologies — including AI-powered diagnostics, robotics, and minimally invasive devices — aligned with national health priorities. This aims to reduce import dependency and cut costs by 3-5 times, making advanced healthcare more accessible to the population.

Context and Background: India’s Research Landscape and RDI Gaps

Historically, India’s investment in research and development has hovered below the global average of around 2.5% of GDP, with private sector contributions particularly lagging, accounting for less than 65% of the total gross expenditure on R&D (GERD). The Rs 1 lakh crore fund marks a pivotal response to this challenge. The government has simultaneously boosted public investments, with the Department of Science and Technology’s budget jumping from Rs 2,777 crore in 2014 to Rs 28,509 crore in the fiscal year 2025-26.

ANRF’s role extends beyond funding to building an integrated research ecosystem connecting industry, academia, and government bodies through programs like Partnerships for Accelerated Innovation and Research (PAIR), designed to catalyze transformative research across India’s diverse scholarly institutions and regions.

Implications for Public Health and Broader Economy

The controlled but catalytic injection of Rs 1 lakh crore into private-sector RDI is poised to invigorate medical research pipelines, spur affordable technology solutions, and foster innovation ecosystems that stimulate economic growth and employment. Such financing mechanisms enable Indian startups and enterprises to compete globally in emerging domains like artificial intelligence in healthcare, biotech, and green technologies—which have direct implications for population health outcomes, sustainability, and national self-reliance.

The facilitation of indigenous MedTech innovations, in particular, can help democratize access to critical health technologies. By supporting device development for minimally invasive surgeries, diagnostic tools, and AI-driven analytics, the scheme promises not only to enhance quality healthcare delivery but also to reduce costs and inefficiencies in the health system.

Potential Limitations and Balanced Viewpoints

While widely hailed, there have been analytical concerns about the potential corporatization of research with significant private sector influence possibly skewing funding priorities away from fundamental or public health research towards profit-driven projects. Transparency and effective oversight are crucial to ensure broad stakeholder participation and balanced outcomes reflecting national and societal needs.

Moreover, the scale of funds and long-term horizon imply that tangible outcomes may take years to fully materialize. Persistent monitoring, stakeholder engagement, and periodic impact assessments will be essential to maximize return on social and economic investments.

Practical Takeaways for Readers

For healthcare professionals and consumers alike, the Rs 1 lakh crore fund represents a hopeful step toward improving the availability and affordability of cutting-edge health technologies in India. Increased R&D funding in diagnostics, MedTech, and digital health tools may soon translate into more effective disease management options and wellness products accessible at local and national levels.

Citizens interested in innovation might watch for upcoming calls for research proposals and funding opportunities under ANRF’s umbrella, which favors scalable, indigenously developed technologies. For industries and startups, this fund signals greater support and easier access to patient capital, encouraging more innovation ventures aligned with national health priorities.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References